ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

10,403Medicare Part D Prescriptions Filled, Including Refills

Rank: 471 out of 4623

$606K Total Retail Price of All Prescriptions

Rank: 493 out of 4623

523 Patients Receiving at Least One Drug in Part D
68%Patients 65 Years and Older
84% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Texas
Lower avg

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

20% of this provider’s 523 patients filled at least one prescription for a schedule three drug, compared to an average of 14%.

Risky Drugs to Seniors

1% of this provider’s 7,767 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

23% of this provider’s prescriptions were for brand-name drugs, compared to an average of 25%.

Prescription Price

$58 was the average price of a prescription from this provider, compared to $61 among peers.

Prescriptions per Patient

20 is the average number of prescriptions (including refills) per patient, compared to an average of 17.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Texas
HYDROCODONE-ACETAMINOPHEN 425 283 S3 1 3
AMLODIPINE BESYLATE 376 301 2 5
LISINOPRIL 327 245 3 4
TRAMADOL HCL 311 194 4 15
SIMVASTATIN 307 248 5 2
FUROSEMIDE 299 240 6 8
DONEPEZIL HCL 281 262 7 30
NAMENDA 278 258 8 36
METOPROLOL TARTRATE 277 200 9 9
OMEPRAZOLE 269 193 10 7
TRAZODONE HCL 260 201 11 42
LEVOTHYROXINE SODIUM 259 189 12 1
QUETIAPINE FUMARATE 162 140 13 74
HYDRALAZINE HCL 153 120 14 99
ENALAPRIL MALEATE 148 126 15 41
LEVETIRACETAM 146 89 16 114
CITALOPRAM HBR 142 90 17 23
METFORMIN HCL 141 78 18 6
GLIPIZIDE 141 117 18 49
GABAPENTIN 122 70 20 16
WARFARIN SODIUM 122 115 20 24
NEXIUM 117 95 22 17
METOPROLOL SUCCINATE 115 74 23 13
DOXAZOSIN MESYLATE 89 84 24 98
HYDROCHLOROTHIAZIDE 88 74 25 10
CARVEDILOL 87 73 26 25
RANITIDINE HCL 85 77 27 47
CARBIDOPA-LEVODOPA 83 83 28 116
TAMSULOSIN HCL 81 72 29 29
ZOLPIDEM TARTRATE 79 51 30 18
CLOPIDOGREL 75 65 31 31
LACTULOSE 74 45 32 106
PANTOPRAZOLE SODIUM 73 48 33 35
CLONIDINE HCL 71 32 34 40
SERTRALINE HCL 66 50 35 26
NOVOLIN N 64 45 36 237
LIDODERM 63 40 37 139
PLAVIX 62 50 38 45
FLUTICASONE PROPIONATE 62 34 38 32
POLYETHYLENE GLYCOL 3350 60 52 40 91
DIOVAN 58 43 41 39
POTASSIUM CHLORIDE 57 43 42 14
METOCLOPRAMIDE HCL 54 26 43 126
BACLOFEN 53 22 44 133
MEGESTROL ACETATE 53 52 R 44 145
HUMULIN N 52 23 46 303
SUCRALFATE 51 35 47 183
NYSTATIN 50 40 48 175
ISOSORBIDE MONONITRATE ER 50 45 48 60
DIGOXIN 50 50 48 58
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on May 16, 2013.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.